INSIGHTS ON DRUG DEVELOPMENT

• Scale-Up Of AAV Production In Fixed-Bed Bioreactors

  Consistent AAV production is critical for manufacturing. See how aligned strategies deliver comparable cell growth, metabolic trends, and rAAV5 titers from development through production.

• The Simplest, Most Powerful Digital PCR Workflow Family

  Scalable digital PCR provides high-throughput automation for up to 384 samples. Support seven-color multiplexing and 3D data analysis to achieve superior sensitivity and streamlined laboratory workflows.

• The Body As A Bioreactor – Delivering The Vision

  Making the body a bioreactor requires precise delivery to selected cells. See how lipid nanoparticles, manufacturing science, and biology are converging to overcome biological barriers and improve the targeting of advanced therapies.

• Characterizing Binding Interactions By ITC

  Isothermal Titration Calorimetry is a powerful technique for analyzing biochemical binding events, which is crucial for understanding molecular interactions and enzyme kinetics in biomedical research.

• ADC Development Grows More Complex — SPR Insights Bring Clarity

  4/14/2026

  Explore how real-time kinetic analysis reveals how conjugation, linker chemistry, and drug loading influence antibody–antigen interactions, while enabling sensitive detection of anti-drug antibodies.

• Real-Time Growth Monitoring Of Spheroids In Round Bottom Microplates

  11/7/2025

  Real-time spheroid monitoring combines brightfield and fluorescence imaging with automated analysis. Find out how this workflow enhances reproducibility and supports high-content 3D cell culture applications.

• AustinPx Site Tour

  5/2/2025

  Take a virtual tour of AustinPx to explore advanced facilities, including KinetiSol™ technology, and discover how we enable scalable, sustainable performance.

• 5 Key Considerations For Companies Outsourcing Process Development

  6/9/2025

  Venture capital in biotech remains strong post-pandemic, especially in cell and gene therapies. Discover five key factors to help companies choose between in-house and outsourced process development strategies.

• Targeted Modalities Set Elevated Standards For Precision

  4/7/2026

  Explore how targeted modalities like ADCs and TPDs are transforming precision medicine, unlocking new treatment opportunities, and overcoming development challenges to improve patient outcomes.